Adverse events of gastric electrical stimulators recorded in the Manufacturer and User Device Experience (MAUDE) Registry
The role of gastric electrical stimulation for patients with refractory symptoms of gastroparesis remains controversial. Open label studies suggest benefit while randomized controlled trials did not demonstrate differences between active and sham intervention. Using a voluntary reporting system of t...
Ausführliche Beschreibung
Autor*in: |
Bielefeldt, Klaus [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2017 |
---|
Umfang: |
5 |
---|
Übergeordnetes Werk: |
Enthalten in: Healing the Amazon - Watts, Jonathan ELSEVIER, 2022, basic and clinical, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:202 ; year:2017 ; pages:40-44 ; extent:5 |
Links: |
---|
DOI / URN: |
10.1016/j.autneu.2016.01.003 |
---|
Katalog-ID: |
ELV025128256 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV025128256 | ||
003 | DE-627 | ||
005 | 20230623175815.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.autneu.2016.01.003 |2 doi | |
028 | 5 | 2 | |a GBVA2017006000011.pica |
035 | |a (DE-627)ELV025128256 | ||
035 | |a (ELSEVIER)S1566-0702(16)30003-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
100 | 1 | |a Bielefeldt, Klaus |e verfasserin |4 aut | |
245 | 1 | 0 | |a Adverse events of gastric electrical stimulators recorded in the Manufacturer and User Device Experience (MAUDE) Registry |
264 | 1 | |c 2017 | |
300 | |a 5 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a The role of gastric electrical stimulation for patients with refractory symptoms of gastroparesis remains controversial. Open label studies suggest benefit while randomized controlled trials did not demonstrate differences between active and sham intervention. Using a voluntary reporting system of the Federal Drug Administration, we examined the type and frequency of adverse events. | ||
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Watts, Jonathan ELSEVIER |t Healing the Amazon |d 2022 |d basic and clinical |g Amsterdam [u.a.] |w (DE-627)ELV007838476 |
773 | 1 | 8 | |g volume:202 |g year:2017 |g pages:40-44 |g extent:5 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.autneu.2016.01.003 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
951 | |a AR | ||
952 | |d 202 |j 2017 |h 40-44 |g 5 | ||
953 | |2 045F |a 610 |
author_variant |
k b kb |
---|---|
matchkey_str |
bielefeldtklaus:2017----:deseetogsrclcrcltmltrrcreiteauatrrnuedv |
hierarchy_sort_str |
2017 |
publishDate |
2017 |
allfields |
10.1016/j.autneu.2016.01.003 doi GBVA2017006000011.pica (DE-627)ELV025128256 (ELSEVIER)S1566-0702(16)30003-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 Bielefeldt, Klaus verfasserin aut Adverse events of gastric electrical stimulators recorded in the Manufacturer and User Device Experience (MAUDE) Registry 2017 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The role of gastric electrical stimulation for patients with refractory symptoms of gastroparesis remains controversial. Open label studies suggest benefit while randomized controlled trials did not demonstrate differences between active and sham intervention. Using a voluntary reporting system of the Federal Drug Administration, we examined the type and frequency of adverse events. Enthalten in Elsevier Science Watts, Jonathan ELSEVIER Healing the Amazon 2022 basic and clinical Amsterdam [u.a.] (DE-627)ELV007838476 volume:202 year:2017 pages:40-44 extent:5 https://doi.org/10.1016/j.autneu.2016.01.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 202 2017 40-44 5 045F 610 |
spelling |
10.1016/j.autneu.2016.01.003 doi GBVA2017006000011.pica (DE-627)ELV025128256 (ELSEVIER)S1566-0702(16)30003-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 Bielefeldt, Klaus verfasserin aut Adverse events of gastric electrical stimulators recorded in the Manufacturer and User Device Experience (MAUDE) Registry 2017 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The role of gastric electrical stimulation for patients with refractory symptoms of gastroparesis remains controversial. Open label studies suggest benefit while randomized controlled trials did not demonstrate differences between active and sham intervention. Using a voluntary reporting system of the Federal Drug Administration, we examined the type and frequency of adverse events. Enthalten in Elsevier Science Watts, Jonathan ELSEVIER Healing the Amazon 2022 basic and clinical Amsterdam [u.a.] (DE-627)ELV007838476 volume:202 year:2017 pages:40-44 extent:5 https://doi.org/10.1016/j.autneu.2016.01.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 202 2017 40-44 5 045F 610 |
allfields_unstemmed |
10.1016/j.autneu.2016.01.003 doi GBVA2017006000011.pica (DE-627)ELV025128256 (ELSEVIER)S1566-0702(16)30003-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 Bielefeldt, Klaus verfasserin aut Adverse events of gastric electrical stimulators recorded in the Manufacturer and User Device Experience (MAUDE) Registry 2017 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The role of gastric electrical stimulation for patients with refractory symptoms of gastroparesis remains controversial. Open label studies suggest benefit while randomized controlled trials did not demonstrate differences between active and sham intervention. Using a voluntary reporting system of the Federal Drug Administration, we examined the type and frequency of adverse events. Enthalten in Elsevier Science Watts, Jonathan ELSEVIER Healing the Amazon 2022 basic and clinical Amsterdam [u.a.] (DE-627)ELV007838476 volume:202 year:2017 pages:40-44 extent:5 https://doi.org/10.1016/j.autneu.2016.01.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 202 2017 40-44 5 045F 610 |
allfieldsGer |
10.1016/j.autneu.2016.01.003 doi GBVA2017006000011.pica (DE-627)ELV025128256 (ELSEVIER)S1566-0702(16)30003-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 Bielefeldt, Klaus verfasserin aut Adverse events of gastric electrical stimulators recorded in the Manufacturer and User Device Experience (MAUDE) Registry 2017 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The role of gastric electrical stimulation for patients with refractory symptoms of gastroparesis remains controversial. Open label studies suggest benefit while randomized controlled trials did not demonstrate differences between active and sham intervention. Using a voluntary reporting system of the Federal Drug Administration, we examined the type and frequency of adverse events. Enthalten in Elsevier Science Watts, Jonathan ELSEVIER Healing the Amazon 2022 basic and clinical Amsterdam [u.a.] (DE-627)ELV007838476 volume:202 year:2017 pages:40-44 extent:5 https://doi.org/10.1016/j.autneu.2016.01.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 202 2017 40-44 5 045F 610 |
allfieldsSound |
10.1016/j.autneu.2016.01.003 doi GBVA2017006000011.pica (DE-627)ELV025128256 (ELSEVIER)S1566-0702(16)30003-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 Bielefeldt, Klaus verfasserin aut Adverse events of gastric electrical stimulators recorded in the Manufacturer and User Device Experience (MAUDE) Registry 2017 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The role of gastric electrical stimulation for patients with refractory symptoms of gastroparesis remains controversial. Open label studies suggest benefit while randomized controlled trials did not demonstrate differences between active and sham intervention. Using a voluntary reporting system of the Federal Drug Administration, we examined the type and frequency of adverse events. Enthalten in Elsevier Science Watts, Jonathan ELSEVIER Healing the Amazon 2022 basic and clinical Amsterdam [u.a.] (DE-627)ELV007838476 volume:202 year:2017 pages:40-44 extent:5 https://doi.org/10.1016/j.autneu.2016.01.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 202 2017 40-44 5 045F 610 |
language |
English |
source |
Enthalten in Healing the Amazon Amsterdam [u.a.] volume:202 year:2017 pages:40-44 extent:5 |
sourceStr |
Enthalten in Healing the Amazon Amsterdam [u.a.] volume:202 year:2017 pages:40-44 extent:5 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Healing the Amazon |
authorswithroles_txt_mv |
Bielefeldt, Klaus @@aut@@ |
publishDateDaySort_date |
2017-01-01T00:00:00Z |
hierarchy_top_id |
ELV007838476 |
dewey-sort |
3610 |
id |
ELV025128256 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV025128256</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623175815.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.autneu.2016.01.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2017006000011.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV025128256</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1566-0702(16)30003-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bielefeldt, Klaus</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Adverse events of gastric electrical stimulators recorded in the Manufacturer and User Device Experience (MAUDE) Registry</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The role of gastric electrical stimulation for patients with refractory symptoms of gastroparesis remains controversial. Open label studies suggest benefit while randomized controlled trials did not demonstrate differences between active and sham intervention. Using a voluntary reporting system of the Federal Drug Administration, we examined the type and frequency of adverse events.</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Watts, Jonathan ELSEVIER</subfield><subfield code="t">Healing the Amazon</subfield><subfield code="d">2022</subfield><subfield code="d">basic and clinical</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007838476</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:202</subfield><subfield code="g">year:2017</subfield><subfield code="g">pages:40-44</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.autneu.2016.01.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">202</subfield><subfield code="j">2017</subfield><subfield code="h">40-44</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Bielefeldt, Klaus |
spellingShingle |
Bielefeldt, Klaus ddc 610 Adverse events of gastric electrical stimulators recorded in the Manufacturer and User Device Experience (MAUDE) Registry |
authorStr |
Bielefeldt, Klaus |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007838476 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 Adverse events of gastric electrical stimulators recorded in the Manufacturer and User Device Experience (MAUDE) Registry |
topic |
ddc 610 |
topic_unstemmed |
ddc 610 |
topic_browse |
ddc 610 |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
hierarchy_parent_title |
Healing the Amazon |
hierarchy_parent_id |
ELV007838476 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Healing the Amazon |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV007838476 |
title |
Adverse events of gastric electrical stimulators recorded in the Manufacturer and User Device Experience (MAUDE) Registry |
ctrlnum |
(DE-627)ELV025128256 (ELSEVIER)S1566-0702(16)30003-0 |
title_full |
Adverse events of gastric electrical stimulators recorded in the Manufacturer and User Device Experience (MAUDE) Registry |
author_sort |
Bielefeldt, Klaus |
journal |
Healing the Amazon |
journalStr |
Healing the Amazon |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2017 |
contenttype_str_mv |
zzz |
container_start_page |
40 |
author_browse |
Bielefeldt, Klaus |
container_volume |
202 |
physical |
5 |
class |
610 610 DE-600 |
format_se |
Elektronische Aufsätze |
author-letter |
Bielefeldt, Klaus |
doi_str_mv |
10.1016/j.autneu.2016.01.003 |
dewey-full |
610 |
title_sort |
adverse events of gastric electrical stimulators recorded in the manufacturer and user device experience (maude) registry |
title_auth |
Adverse events of gastric electrical stimulators recorded in the Manufacturer and User Device Experience (MAUDE) Registry |
abstract |
The role of gastric electrical stimulation for patients with refractory symptoms of gastroparesis remains controversial. Open label studies suggest benefit while randomized controlled trials did not demonstrate differences between active and sham intervention. Using a voluntary reporting system of the Federal Drug Administration, we examined the type and frequency of adverse events. |
abstractGer |
The role of gastric electrical stimulation for patients with refractory symptoms of gastroparesis remains controversial. Open label studies suggest benefit while randomized controlled trials did not demonstrate differences between active and sham intervention. Using a voluntary reporting system of the Federal Drug Administration, we examined the type and frequency of adverse events. |
abstract_unstemmed |
The role of gastric electrical stimulation for patients with refractory symptoms of gastroparesis remains controversial. Open label studies suggest benefit while randomized controlled trials did not demonstrate differences between active and sham intervention. Using a voluntary reporting system of the Federal Drug Administration, we examined the type and frequency of adverse events. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
title_short |
Adverse events of gastric electrical stimulators recorded in the Manufacturer and User Device Experience (MAUDE) Registry |
url |
https://doi.org/10.1016/j.autneu.2016.01.003 |
remote_bool |
true |
ppnlink |
ELV007838476 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
doi_str |
10.1016/j.autneu.2016.01.003 |
up_date |
2024-07-06T16:45:24.373Z |
_version_ |
1803848855714791424 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV025128256</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623175815.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.autneu.2016.01.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2017006000011.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV025128256</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1566-0702(16)30003-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bielefeldt, Klaus</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Adverse events of gastric electrical stimulators recorded in the Manufacturer and User Device Experience (MAUDE) Registry</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The role of gastric electrical stimulation for patients with refractory symptoms of gastroparesis remains controversial. Open label studies suggest benefit while randomized controlled trials did not demonstrate differences between active and sham intervention. Using a voluntary reporting system of the Federal Drug Administration, we examined the type and frequency of adverse events.</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Watts, Jonathan ELSEVIER</subfield><subfield code="t">Healing the Amazon</subfield><subfield code="d">2022</subfield><subfield code="d">basic and clinical</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007838476</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:202</subfield><subfield code="g">year:2017</subfield><subfield code="g">pages:40-44</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.autneu.2016.01.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">202</subfield><subfield code="j">2017</subfield><subfield code="h">40-44</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.399523 |